The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs
Clinical trial NCT06325826 · UNKNOWN
Trial details
- NCT number
- NCT06325826
- Sponsor
- Egyptian Liver Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-06-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.